Skip to main navigation
Contact UsHome

Combined Mega Menu

  • Patients & Caregivers Overview
    • Rare Genetic Diseases
    • Cancer
  • Therapeutic Focus
    • Rare Genetic Diseases
    • Cancer
  • Research & Development
    • Technology
    • AEB1102
    • Preclinical Candidates
    • Publications
  • Careers
    • Living in Austin
    • Benefits
    • Career Opportunities
  • Investors
    • Overview
    • News & Events
      • Presentations & Events
      • Press Releases
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Financials
      • SEC Filings
      • Annual Report and Proxy
      • Quarterly Earnings
    • Corporate Governance
      • Governance Highlights
      • Committee Composition
      • Team
      • Board of Directors
    • Shareholder Services
      • Investor FAQs
      • Info Request
      • E-mail Alerts
      • IR & Media Contacts
  • About Us
    • Team
    • Board of Directors
    • Scientific Advisors
    • Contact Us

Investors

Governance Highlights



Committee Charters

Title
  • Add Files
    Audit Committee 166.2 KB
  • Add Files
    Compensation Committee 200.7 KB
  • Add Files
    Nominating and Corporate Governance Committee 159.3 KB

Governance Documents

Title
  • Add Files
    Whistleblower and Complaint Policy 90 KB
  • Add Files
    Code of Conduct and Ethics 119.4 KB
  • Add Files
    Corporate Governance Guidelines 165.7 KB

Shareholder Tools

  • Print Page
  • RSS Feeds
  • E-mail Alerts
  • IR & Media Contacts

Aeglea BioTherapeutics, Inc.
901 S. MoPac Expressway, Barton Oaks Plaza One, Suite 250, Austin, TX 78746

Phone: (512) 942-2935 Email: investors@aegleabio.com

 

© Aeglea BioTherapeutics, Inc. All Rights Reserved.

Privacy Policy | Terms of Use | Purchase Terms